JPRN-UMIN000012180已完成4 期
Cilostazol Stroke Prevention Study for Antiplatelet Combination - CSPS.com (Cilostazol Stroke Prevention Study. Combination)
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 1,884
研究概览
简要总结
The study found the risk of another ischemic stroke was halved for patients who took Pletal plus aspirin or clopidogrel, versus those who took aspirin or clopidogrel alone. Specially, 29 of 913 patients (3.2 percent) who took Pletal plus another blood thinner went on to have another stroke, compared to 64 of 926 patients (6.9 percent) who took aspirin or clopidogrel alone, the investigators found.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with emboligenic heart disease 2) Patients taking any anticoagulant agents 3) Patients who cannot undergo MRI examination for reasons such as claustrophobia and implanted pacemaker 4) Patients scheduled to undergo any surgery, such as percutaneous angioplasty, stent placement, and bypass grafting, during the study period 5) Patients with a drug-eluting coronary stent implanted within one year 6) Patients with a history of symptomatic non-traumatic intracranial hemorrhage, any other hemorrhagic disease (eg, active peptic ulcer), bleeding predisposition, or blood clotting disorders 7) Patients with a history of hypersensitivity to cilostazol 8) Patients with congestive heart failure or uncontrolled angina pectoris 9) Patients with thrombocytopenia (platelet count <= 100,000/mm3) 10) Patients with severe liver or renal dysfunction 11) Women who are pregnant, breast-feeding, or of child-bearing potential 12) Patients with a malignant tumor requiring treatment 13) Patients who are taking aspirin, and meet any of the following criteria: -History of hypersensitivity to aspirin or salicylic acid analogues -Current peptic ulcer -Aspirin-induced asthma or its history 14) Patients who are taking clopidogrel, and meet the following criterion: -History of hypersensitivity to clopidogrel 15) Patients who are participating in any other clinical studies 16) Patients considered by the investigator/subinvestigator to be unsuitable for participating in this study
研究者
相似试验
已完成
4 期
Cilostazol Stroke Prevention Study for Antiplatelet CombinationNoncardioembolic Cerebral InfarctionNCT01995370Japan Cardiovascular Research Foundation1,884
已完成
3 期
Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction.Cerebral InfarctionNCT00766545Otsuka Pharmaceutical Co., Ltd.1,095
Unknown
4 期
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhageBrain IschemiaIntracranial HemorrhagesNCT01013532Asan Medical Center1,600
Unknown
4 期
PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT StudyBrain IschemiaIntracranial HemorrhagesNCT02483169Asan Medical Center800
Unknown
4 期
Sufficient Treatment of Peripheral Intervention by CilostazolArteriosclerosis ObliteransNCT00912756Kansai Rosai Hospital200